Concepts (126)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Asthma | 22 | 2024 | 742 | 8.550 |
Why?
|
| Metformin | 4 | 2021 | 137 | 2.090 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 5 | 2024 | 594 | 1.570 |
Why?
|
| Obesity | 6 | 2022 | 2084 | 1.420 |
Why?
|
| Tobacco Smoke Pollution | 2 | 2019 | 76 | 1.180 |
Why?
|
| Glucose | 2 | 2023 | 876 | 1.180 |
Why?
|
| Particulate Matter | 3 | 2024 | 70 | 1.170 |
Why?
|
| Environmental Exposure | 3 | 2022 | 216 | 1.120 |
Why?
|
| Air Filters | 2 | 2024 | 2 | 1.110 |
Why?
|
| Diabetes Mellitus, Type 2 | 3 | 2021 | 1204 | 1.110 |
Why?
|
| Pulmonary Emphysema | 3 | 2024 | 93 | 1.060 |
Why?
|
| Adrenal Cortex Hormones | 2 | 2024 | 315 | 0.950 |
Why?
|
| Wildfires | 1 | 2024 | 1 | 0.920 |
Why?
|
| Patient Reported Outcome Measures | 1 | 2024 | 162 | 0.810 |
Why?
|
| Triglycerides | 2 | 2023 | 556 | 0.800 |
Why?
|
| Schools | 2 | 2022 | 211 | 0.780 |
Why?
|
| Bronchitis, Chronic | 1 | 2021 | 18 | 0.750 |
Why?
|
| Diabetes Mellitus | 2 | 2019 | 845 | 0.740 |
Why?
|
| Hypoglycemic Agents | 1 | 2024 | 412 | 0.730 |
Why?
|
| Urban Population | 2 | 2019 | 216 | 0.710 |
Why?
|
| Forced Expiratory Volume | 1 | 2021 | 169 | 0.700 |
Why?
|
| Air Pollution, Indoor | 4 | 2021 | 30 | 0.690 |
Why?
|
| Insulin Resistance | 2 | 2025 | 632 | 0.680 |
Why?
|
| Smokers | 1 | 2019 | 39 | 0.640 |
Why?
|
| Family Characteristics | 1 | 2019 | 77 | 0.620 |
Why?
|
| Metabolic Syndrome | 1 | 2021 | 323 | 0.590 |
Why?
|
| Smoking | 2 | 2020 | 1028 | 0.570 |
Why?
|
| Humans | 38 | 2025 | 122362 | 0.540 |
Why?
|
| Air Pollutants | 3 | 2022 | 100 | 0.500 |
Why?
|
| Primary Health Care | 1 | 2019 | 748 | 0.420 |
Why?
|
| United States | 8 | 2022 | 10486 | 0.400 |
Why?
|
| Cohort Studies | 6 | 2023 | 4651 | 0.400 |
Why?
|
| Adult | 10 | 2025 | 28730 | 0.380 |
Why?
|
| Air Pollution | 2 | 2022 | 66 | 0.370 |
Why?
|
| Spirometry | 2 | 2022 | 74 | 0.360 |
Why?
|
| Respiratory Function Tests | 2 | 2021 | 194 | 0.360 |
Why?
|
| Respiratory Sounds | 2 | 2022 | 68 | 0.360 |
Why?
|
| Cardiovascular Diseases | 1 | 2022 | 1821 | 0.350 |
Why?
|
| Retrospective Studies | 8 | 2023 | 15844 | 0.320 |
Why?
|
| Female | 17 | 2025 | 64899 | 0.320 |
Why?
|
| Nutrition Surveys | 2 | 2021 | 278 | 0.310 |
Why?
|
| Surveys and Questionnaires | 1 | 2018 | 3625 | 0.310 |
Why?
|
| Male | 14 | 2025 | 59540 | 0.310 |
Why?
|
| Hospitalization | 3 | 2021 | 1727 | 0.300 |
Why?
|
| Oximetry | 3 | 2023 | 160 | 0.290 |
Why?
|
| Middle Aged | 9 | 2025 | 25624 | 0.290 |
Why?
|
| Pediatric Obesity | 2 | 2023 | 365 | 0.290 |
Why?
|
| Risk Factors | 4 | 2023 | 9899 | 0.290 |
Why?
|
| Blood Glucose | 2 | 2021 | 1103 | 0.270 |
Why?
|
| Disease Progression | 3 | 2021 | 1990 | 0.250 |
Why?
|
| Biomarkers | 3 | 2023 | 2932 | 0.240 |
Why?
|
| Comorbidity | 2 | 2021 | 1490 | 0.240 |
Why?
|
| Administration, Inhalation | 1 | 2024 | 177 | 0.230 |
Why?
|
| Lymphadenopathy | 1 | 2024 | 30 | 0.220 |
Why?
|
| Smoke | 1 | 2024 | 46 | 0.220 |
Why?
|
| Child | 9 | 2023 | 24086 | 0.220 |
Why?
|
| Treatment Outcome | 4 | 2024 | 12038 | 0.210 |
Why?
|
| Emphysema | 1 | 2024 | 65 | 0.210 |
Why?
|
| Neck Pain | 1 | 2022 | 19 | 0.210 |
Why?
|
| Achievement | 1 | 2022 | 32 | 0.210 |
Why?
|
| Baltimore | 2 | 2019 | 13 | 0.210 |
Why?
|
| Oxygen | 2 | 2023 | 546 | 0.200 |
Why?
|
| Sarcoidosis | 1 | 2022 | 63 | 0.200 |
Why?
|
| Blast Injuries | 1 | 2022 | 58 | 0.200 |
Why?
|
| Dyspnea | 2 | 2022 | 149 | 0.190 |
Why?
|
| Protective Agents | 1 | 2021 | 30 | 0.190 |
Why?
|
| Acute Disease | 1 | 2024 | 1089 | 0.190 |
Why?
|
| Cost-Benefit Analysis | 1 | 2024 | 492 | 0.190 |
Why?
|
| Respiratory Physiological Phenomena | 1 | 2021 | 17 | 0.190 |
Why?
|
| Information Systems | 1 | 2021 | 35 | 0.180 |
Why?
|
| Veterans | 2 | 2022 | 1710 | 0.180 |
Why?
|
| Symptom Assessment | 1 | 2021 | 96 | 0.180 |
Why?
|
| Emigrants and Immigrants | 1 | 2022 | 148 | 0.180 |
Why?
|
| Positive-Pressure Respiration, Intrinsic | 1 | 2020 | 2 | 0.180 |
Why?
|
| Students | 1 | 2022 | 248 | 0.180 |
Why?
|
| Aged | 5 | 2021 | 18777 | 0.180 |
Why?
|
| Lung | 3 | 2025 | 1472 | 0.170 |
Why?
|
| Sleep Apnea, Obstructive | 1 | 2023 | 191 | 0.170 |
Why?
|
| Overweight | 2 | 2023 | 339 | 0.170 |
Why?
|
| Fatty Acids, Omega-6 | 1 | 2019 | 16 | 0.170 |
Why?
|
| Propensity Score | 1 | 2019 | 202 | 0.160 |
Why?
|
| Fatty Acids, Omega-3 | 1 | 2019 | 69 | 0.160 |
Why?
|
| Cough | 1 | 2018 | 87 | 0.150 |
Why?
|
| Respiration, Artificial | 1 | 2020 | 451 | 0.140 |
Why?
|
| Intensive Care Units | 1 | 2020 | 475 | 0.130 |
Why?
|
| Proportional Hazards Models | 1 | 2019 | 1298 | 0.130 |
Why?
|
| Cross-Sectional Studies | 2 | 2022 | 3294 | 0.130 |
Why?
|
| Inflammation | 1 | 2022 | 1392 | 0.130 |
Why?
|
| Referral and Consultation | 1 | 2019 | 525 | 0.120 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2022 | 617 | 0.120 |
Why?
|
| Follow-Up Studies | 2 | 2021 | 5011 | 0.120 |
Why?
|
| Aged, 80 and over | 3 | 2021 | 6287 | 0.120 |
Why?
|
| Child, Preschool | 3 | 2019 | 13802 | 0.120 |
Why?
|
| Databases, Factual | 1 | 2019 | 1159 | 0.120 |
Why?
|
| Quality of Life | 1 | 2024 | 1913 | 0.120 |
Why?
|
| Electronic Health Records | 1 | 2021 | 691 | 0.110 |
Why?
|
| Body Mass Index | 1 | 2018 | 1459 | 0.100 |
Why?
|
| Emergency Service, Hospital | 1 | 2019 | 1059 | 0.100 |
Why?
|
| Reproducibility of Results | 1 | 2018 | 2797 | 0.100 |
Why?
|
| Tidal Volume | 2 | 2022 | 36 | 0.090 |
Why?
|
| Adolescent | 2 | 2019 | 18951 | 0.090 |
Why?
|
| Severity of Illness Index | 1 | 2018 | 2808 | 0.090 |
Why?
|
| Prognosis | 1 | 2018 | 4487 | 0.080 |
Why?
|
| Young Adult | 1 | 2019 | 8769 | 0.060 |
Why?
|
| Snoring | 1 | 2023 | 15 | 0.050 |
Why?
|
| Afghanistan | 1 | 2022 | 11 | 0.050 |
Why?
|
| Iraq | 1 | 2022 | 9 | 0.050 |
Why?
|
| Environmental Monitoring | 1 | 2021 | 63 | 0.050 |
Why?
|
| Lung Diseases | 1 | 2025 | 384 | 0.050 |
Why?
|
| Cigarette Smoking | 1 | 2021 | 55 | 0.050 |
Why?
|
| Hypoxia | 1 | 2022 | 246 | 0.040 |
Why?
|
| Peru | 1 | 2020 | 45 | 0.040 |
Why?
|
| Proteomics | 1 | 2024 | 475 | 0.040 |
Why?
|
| Prospective Studies | 2 | 2022 | 5959 | 0.040 |
Why?
|
| Minority Groups | 1 | 2022 | 250 | 0.040 |
Why?
|
| Seasons | 1 | 2021 | 299 | 0.040 |
Why?
|
| Neuropsychological Tests | 1 | 2022 | 920 | 0.040 |
Why?
|
| Poverty | 1 | 2021 | 412 | 0.040 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2025 | 2030 | 0.030 |
Why?
|
| Gene Expression Profiling | 1 | 2024 | 1674 | 0.030 |
Why?
|
| Intubation, Intratracheal | 1 | 2020 | 289 | 0.030 |
Why?
|
| Hospital Mortality | 1 | 2020 | 994 | 0.030 |
Why?
|
| Pandemics | 1 | 2022 | 1101 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 1 | 2021 | 4362 | 0.030 |
Why?
|
| Mice | 1 | 2021 | 17550 | 0.010 |
Why?
|
| Animals | 1 | 2021 | 33728 | 0.010 |
Why?
|